Antiviral Enantiomeric Preference for 5′-Noraristeromycin

Journal of Medicinal Chemistry

Volumn 37, Issue 4, 1994, Pages 551-554

  Siddiqi, Suhaib M ^a   Chen, Xing ^a   Schneller, Stewart W ^a   Ikeda, Satoru ^b   Snoeck, Robert ^b   Andrei, Graciela ^b   Balzarini, Jan ^b   De Clercq, Erik ^b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

5' NORARISTEROMYCIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CYTOSTASIS; DRUG ACTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; ENANTIOMER; ENZYME INHIBITION; HUMAN; HUMAN CELL; NONHUMAN; STRUCTURE ACTIVITY RELATION;

ADENOSINE; ANIMAL; ANTIVIRAL AGENTS; HUMAN; HYDROLASES; LEUKEMIA L1210; MICE; MICROBIAL SENSITIVITY TESTS; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR CELLS, CULTURED;

EID: 0028347542     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm00030a014     Document Type: Note

References (31)

1. De Clercq, E. S-Adenosylhomocysteine Hydrolase Inhibitors as Broad Spectrum Antiviral Agents. Biochem. Pharmacol. 1987, 36, 2567-2575.
2. Wolfe, M. S.; Borchardt, R. T. S-Adenosyl-L-homocysteine Hydrolase as a Target for Antiviral Chemotherapy. J. Med. Chem. 1991, 34, 1521-1530.
3. Patil, S. D.; Schneller, S. W.; Hosoya, M.; Snoeck, R.; Andrei, G.; Balzarini, J.; DeClercq, E. Synthesis and Antiviral Properties of (±)-5′-Noraristeromycin and Related Purine Carbocyclic Nucleosides. A New Lead for Anti-Human Cytomegalovirus Agent Design. J. Med. Chem. 1992, 35, 3372-3377.
4. Siddiqi, S. M.; Chen, X.; Schneller, S. W. Enantiospecific Synthesis of 5′-Noraristeromycin and Its 7-Deaza Derivative and a Formal Synthesis of (-)-5′-Homoaristeromycin. Nucleosides Nucleotides 1993, 12, 267-278.
5. Merlo, V.; Reece, F. J.; Roberts, S. M.; Gregson, M.; Storer, M. Synthesis of Optically Active 5′-Noraristeromycin: Enzyme Catalyzed Kinetic Resolution of 9-(4-Hydroxycyclopent-2-enyl)purines. J. Chem. Soc., Perkin Trans. 1 1993, 1717-1718.
6. Herdewijn, P.; Balzarini, J.; DeClercq, E.; Vanderhaeghe, H. Resolution of Aristeromycin Enantiomers. J. Med. Chem. 1985, 28, 1385-1386.
7. Secrist, J. A., III; Montgomery, J. A.; Shealy, Y. F.; O'Dell, C. A.; Clayton, S. J. Resolution of Racemic Carbocyclic Analogues of Purine Nucleosides through the Action of Adenosine Deaminase. Antiviral Activity of the Carbocyclic 2′-Deoxyguanosine Enantiomers. J. Med. Chem. 1987, 30, 746-749.
8. Bennett, L. L., Jr.; Shealy, Y. F.; Allan, P. W.; Rose, L. M.; Shannon, W. M.; Arnett, G. Phosphorylation of the Carbocyclic Analog of 2′-Deoxyguanosine in Cells Infected with Herpes Viruses. Biochem. Pharmacol. 1990, 40, 1515-1522.
9. Vince, R.; Brownell, J. Resolution of Racemic Carbovir and Selective Inhibition of Human Immunodeficiency Virus by the (-) Enantiomer. Biochem. Biophys. Res. Commun. 1990, 168, 912-916.
10. Miller, W. H.; Daluge, S. M.; Garvey, E. P.; Hopkins, S.; Reardon, J. E.; Boyd, F. L.; Miller, R. L. Phosphorylation of Carbovir Enantiomers by Cellular Enzymes Determines the Stereoselectivity of Antiviral Activity. J. Biol. Chem. 1992, 267, 21220-21224.
11. Beach, J. W.; Jeong, L. S.; Alves, A. J.; Pohl, D.; Kim, H. O.; Chang, C.-N.; Doong, S.-L.; Schinazi, R. F.; Cheng, Y.-C.; Chu, C. K. Synthesis of Enantiomerically Pure (2′R,5′S)-(-)-1-[2-(Hydroxymethyl)oxathiolan-5-yl]cytosine as a Potent Antiviral Agent against Hepatitis B Virus (HBV) and Human Immunodeficiency Virus (HIV). J. Org. Chem. 1992, 57, 2217- 2219.
12. Spadari, S.; Maga, G.; Focher, F.; Ciarrocchi, G.; Manservigi, R.; Arcamone, F.; Capobianco, M.; Carcuro, A.; Colonna, F.; Iotti, S.; Garbesi, A. L-Thymidine Is Phosphorylated by Herpes Simplex Virus Type I Thymidine Kinase and Inhibits Viral Growth. J. Med. Chem. 1992, 35, 4214-4220.
13. Kim, H. O.; Shanmuganathan, K.; Alves, A. J.; Jeong, L. S.; Beach, J. W.; Schinazi, R. F.; Chang, C.-N.; Cheng, Y.-C.; Chu, C. K. Potent Anti-HIV and Anti-HBV Activities of (-)-L-β-Dioxolane-C and (+)-L-β-Dioxolane-T and Their Asymmetric Syntheses. Tetrahedron Lett. 1992, 33, 6899-6902.
14. Kim, H. O.; Schinazi, R. F.; Nampalli, S.; Shanmuganathan, K.; Cannon, D. L.; Alves, A. J.; Jeong, L. S.; Beach, J. W.; Chu, C. K. 1,3-Dioxolanylpurine Nucleosides (2R,4R) and (2R,4S) with Selective Anti-HTV-1 Activity in Human Lymphocytes. J. Med. Chem. 1993, 36, 30-37.
15. Tanigawa, Y.; Nishimura, K.; Kawasaki, A.; Murahashi, S.-I. Palladium(0)-Catalyzed Allylic Alkylation and Amination of Allylic Phosphates. Tetrahedron Lett. 1982, 23, 5549-5552.
16. Murahashi, S.-I.; Taniguchi, Y.; Imada, Y.; Tanigawa, Y. Palladium-(O)-Catalyzed Azidation of Allyl Esters. Selective Synthesis of Allyl Azides, Primary Allylamines, and Related Compounds. J. Org. Chem. 1989, 54, 3292-3303.
17. Murahashi, S.-I.; Imada, Y.; Taniguchi, Y.; Higashiura, S. Palladium(0)-Catalyzed Alkoxycarbonylation of Allyl Phosphates and Acetates. J. Org. Chem. 1993, 58,1538-1545.
18. Deardorff, D. R.; Linde, R. G., II; Martin, A. M.; Shulman, M. J. Enantioselective Preparation of Functionalized Cyclopentanoids via a Common Chiral (π-Allyl)palladium Complex. J. Org. Chem. 1989, 54, 2759-2762.
19. Peel, M. R.; Sternbach, D. D.; Johnson, M. R. A Short Enantioselective Synthesis of the Carbocyclic Nucleoside Carbovir. J. Org. Chem. 1991, 56, 4990-4993.
20. Neyts, J.; De Clercq, E. Strategies for the Treatment and Prevention of Cytomegalovirus Infections. Int. J. Antimicrob. Agents 1993, in press.
21. Faulds, D.; Heel, R. C. Ganciclovir. A Review of Its Antiviral Activity, Pharmacokinetic Properties and Therapeutic Efficacy in Cytomegalovirus Infections. Drugs 1990, 39, 597-638.
22. Drew, W. L.; Lalezari, J. P.; Glutzer, E.; Lynch, T.; Flaherty, J.; Martin, J. C.; Fisher, P. E.; Jaffe, H. S. The Safety, Pharmacokinetics, and Anti-CMV Activity of Weekly HPMPC in HIVpositive Patients Excreting CMV. Multidisciplinary Approach to Understanding Cytomegalovirus Disease; Michelson, S., Plotkin, S. A., Eds.; Excerpta Medica, International Congress Series 1032; Elsevier Science Publishers, B. V.: Amsterdam, 1993; pp 287-292.
23. De Clercq, E. Therapeutic Potential of HPMPC as an Antiviral Drug. Rev. Med. Virol. 1993, 3, 85-96.
24. Schols, D.; De Clercq, E.; Balzarini, J.; Baba, M.; Witvrouw, M.; Hosoya, M.; Andrei, G.; Snoeck, R.; Neyts, J.; Pauwels, R.; Nagy, M.; Györgyi-Edelényi, J.; Machovich, R.; Horváth, I.; Löw, M.; Görög, S. Sulphated Polymers are Potent and Selective Inhibitors of Various Enveloped Viruses, including Herpes Simplex Virus, Cytomegalovirus, Vesicular Stomatitis Virus, Respiratory Syncytial Virus, and Toga-, Arena-, and Retroviruses. Antiviral Chem. Chemother. 1990, 1, 233-240.
25. De Clercq, E.; Descamps, J.; Verhelst, G.; Walker, R. T.; Jones, A. S.; Torrence, P.F.; Shugar, D. Comparative Efficacy of Antiherpes Drugs against Different Strains of Herpes Simplex Virus. J. Infect. Dis. 1980, 141, 563-574.
26. De Clercq, E.; Holy, A.; Rosenberg, I.; Sakuma, T.; Balzarini, J.; Maudgal, P. C. A Novel Selective Broad-spectrum anti-DNA Virus Agent. Nature 1986, 323, 464-467.
27. De Clercq, E.; Balzarini, J.; Torrence, P. F.; Mertes, M. P.;Schmidt, C. L.; Shugar, D.; Barr, P. J.; Jones, A. S.; Verhelst, G.; Walker, R. T. Thymidylate Synthetase as a Target Enzyme for the Inhibitory Activity of 5-Substituted 2′-Deoxyuridines on Mouse Leukemia L-1210 Cell Growth. Mol. Pharmacol. 1981, 19, 321-330.
28. Balzarini, J.; Naesens, L.; Herdewijn, P.; Rosenberg, I.; Holy, A.; Pauwels, R.; Baba, M.; Johns, D. G.; De Clercq, E. Marked in vivo Antiretrovirus Activity of 9-(2-Phosphonylmethoxyethyl)adenine, a Selective Anti-Human Immunodeficiency Virus Agent. Proc. Natl. Acad. Sci. U.S.A. 1989, 86, 332-336.
29. Cools, M.; Balzarini, J.; De Clercq, E. Mechanism of Antiviral and Cytotoxic Action of (±)-6′-β-fluoroaristeromycin, a Potent Inhibitor of S-Adenosylhomocysteine Hydrolase. Mol. Pharmacol. 1991, 39, 718-724.
30. Cools, M.;De Clercq, E. Correlation Between the Antiviral Activity of Acyclic and Carbocyclic Adenosine Analogues in Murine L929 Cells and Their Inhibitory Effect on L929 Cell S-Adenosylhomocysteine Hydrolase. Biochem. Pharmacol. 1989, 38, 1061-1067.
31. Snoeck, R.; Sakuma, T.; De Clercq, E.; Rosenberg, I.; Holy, A. (S)-1-(3-Hydroxy-2-phosphonylmethoxypropyl)cytosine, a Potent and Selective Inhibitor of Human Cytomegalovirus Replication. Antimicrob. Agents Chemother. 1988, 32, 1839-1844.